Literature DB >> 16670533

Interstitial pneumonitis after infliximab therapy for Crohn's disease.

Mark Weatherhead, Steven Masson, Stephen J Bourke, Melanie C Gunn, Graham P Burns.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16670533     DOI： 10.1097/01.MIB.0000219811.54115.aa

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  7 in total

1.  A Patient with KL-6 Elevation with Anti-TNFα Who Could Receive Long-Term Use without Interstitial Pneumonia after Class Switch of Anti-TNFα.

Authors:  Takuya Masuda; Atsushi Yoshida; Fumiaki Ueno; Shintaro Hara; Haruaki Nabeta; Shotaro Umezawa; Mayuki Shirai; Yoshihide Morikawa; Toshio Morizane; Yutaka Endo; Toshifumi Hibi
Journal:  Inflamm Intest Dis       Date:  2019-03-25

Review 2.  Pulmonary manifestations of inflammatory bowel disease.

Authors:  Xiao-Qing Ji; Li-Xia Wang; De-Gan Lu
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

Review 3.  Pulmonary manifestations of Crohn's disease.

Authors:  De-Gan Lu; Xiao-Qing Ji; Xun Liu; Hong-Jia Li; Cai-Qing Zhang
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

4.  A case of adalimumab-induced pneumonitis in a 45-year-old man with Crohn's disease.

Authors:  James D Reid; Brian Bressler; John English
Journal:  Can Respir J       Date:  2011 Sep-Oct       Impact factor: 2.409

5.  Adalimumab-induced interstitial pneumonia in a patient with Crohn's disease.

Authors:  María José Casanova; María Chaparro; Claudia Valenzuela; Carolina Cisneros; Javier P Gisbert
Journal:  World J Gastroenterol       Date:  2015-02-21       Impact factor: 5.742

6.  Interstitial pneumonitis associated with infliximab therapy without methotrexate treatment.

Authors:  Hirofumi Taki; Yukio Kawagishi; Koichiro Shinoda; Hiroyuki Hounoki; Reina Ogawa; Eiji Sugiyama; Kazuyuki Tobe
Journal:  Rheumatol Int       Date:  2009-12       Impact factor: 2.631

Review 7.  Noninfectious interstitial lung disease during infliximab therapy: case report and literature review.

Authors:  Roberta Caccaro; Edoardo Savarino; Renata D'Incà; Giacomo Carlo Sturniolo
Journal:  World J Gastroenterol       Date:  2013-08-28       Impact factor: 5.742
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.